New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
08:07 EDTTROVTrovagene announces clinical collaboratoin with Dana-Farber Cancer Institute
Trovagene announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients. Under the agreement, urine samples will be collected from patients with locally advanced or metastatic melanoma known to harbor driver oncogene mutations.
News For TROV From The Last 14 Days
Check below for free stories on TROV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
07:59 EDTTROVTrovagene current levels offer buying opportunity, says Maxim
Subscribe for More Information
August 8, 2014
07:15 EDTTROVTrovagene price target lowered to $8 from $10 at Cantor
Subscribe for More Information
August 7, 2014
16:43 EDTTROVTrovagene reports Q2 EPS (6c), consensus (21c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use